Get the Stockscreener App
92.25
1.84%
1.67
After Hours:
92.15
-0.10
-0.11%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $92.25, with a volume of 14.51M.
It is up +1.84% in the last 24 hours and down -6.65% over the past month.
See More
Previous Close:
$90.58
Open:
$90.705
24h Volume:
14.51M
Relative Volume:
1.11
Market Cap:
$251.88B
Revenue:
$64.17B
Net Income/Loss:
$17.12B
P/E Ratio:
13.71
EPS:
6.73
Net Cash Flow:
$18.10B
1W Performance:
+3.07%
1M Performance:
-6.65%
6M Performance:
-22.12%
1Y Performance:
-27.45%
1-Day Range:
$90.70
$92.35
1-Week Range:
$88.86
$93.06
52-Week Range:
$81.04
$134.63
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
92.25 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
|
LLY
Lilly Eli Co
|
920.63 | 874.97B | 45.04B | 10.59B | 414.30M | 11.71 |
|
NVO
Novo Nordisk Adr
|
90.65 | 402.40B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
ABBV
Abbvie Inc
|
209.03 | 369.01B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
165.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. (MRK): Among the Best Affordable Dividend Stocks to Buy According to Hedge Funds - Insider Monkey
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before - The Bakersfield Californian
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK - GlobeNewswire Inc.
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Middleton & Co. Inc. MA - MarketBeat
Nichols & Pratt Advisers LLP MA Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Purchased by Metis Global Partners LLC - MarketBeat
Poplar Forest Capital LLC Lowers Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by US Bancorp DE - MarketBeat
Fisher Asset Management LLC Grows Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Bank OZK Acquires 2,981 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mutual of America Capital Management LLC Sells 13,866 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Dynasty Wealth Management LLC Invests $480,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Nelson Capital Management LLC Sells 30,402 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.6%Here's What Happened - MarketBeat
Is Merck & Co., Inc. (MRK) the Best Magic Formula Stock for 2025? - Insider Monkey
Berenberg Adjusts Price Target on Merck to $115 From $125, Maintains Buy Rating - Marketscreener.com
Q2 EPS Estimate for Merck & Co., Inc. Reduced by Analyst - MarketBeat
Illumine Investment Management LLC Acquires Shares of 2,940 Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Motco Boosts Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Earnings Update: Merck & Co., Inc. (NYSE:MRK) Just Reported Its Full-Year Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Altrius Capital Management Inc Purchases 6,378 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Argyle Capital Management LLC Has $5.78 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Bought by CORDA Investment Management LLC. - MarketBeat
Proficio Capital Partners LLC Has $107 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Denali Advisors LLC Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Holdings Raised by NewEdge Wealth LLC - MarketBeat
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Merck & Co., Inc. (NYSE:MRK) Trading Up 1.2%Still a Buy? - MarketBeat
Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; ... - The Bakersfield Californian
Merck & Co., Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
Decoding Merck & Co's Options Activity: What's the Big Picture? - Benzinga
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. - The Malaysian Reserve
Merck & Co., Inc. (MRK): One of the Best Vaccine Stocks to Buy According to Hedge Funds - Insider Monkey
QRG Capital Management Inc. Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Alphinity Investment Management Pty Ltd - MarketBeat
Motiv8 Investments LLC Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by FUKOKU MUTUAL LIFE INSURANCE Co - MarketBeat
Alecta Tjanstepension Omsesidigt Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Mn Services Vermogensbeheer B.V. Grows Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Kovack Advisors Inc. Sells 8,570 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Oppenheimer & Co. Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Oppenheimer Asset Management Inc. - MarketBeat
Q1 EPS Forecast for Merck & Co., Inc. Reduced by Analyst - MarketBeat
Schnieders Capital Management LLC Has $1.60 Million Stake in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
SRN Advisors LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Stake Lessened by Lineweaver Wealth Advisors LLC - MarketBeat
Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class ActionContact The Gross Law Firm to Learn More - PR Newswire
WealthShield Partners LLC Has $2.03 Million Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Edge Capital Group LLC Sells 159,265 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):